Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Terveystalo Plc: Managers’ Transactions (Pullola)

Terveystalo Plc: Managers’ Transactions (Pullola) Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 1,783 shares have been purchased to Kristian

Terveystalo Plc: Managers’ Transactions (Andersson Tilk)

Terveystalo Plc: Managers’ Transactions (Andersson Tilk) Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 1,421 shares have been purchased to

Pandemic accelerating digitalisation of the payment market

Developments on the payment market are very rapid and have been given an extra boost by the pandemic. Sweden has long stood out as a country with low cash usage and high use of cards and digital payment solutions, but now the trend is also visible internationally. To meet new developments, the Riksbank has for some time been investigating the possibility, together with other central banks and international organisations, of issuing central bank digital currencies and making international payments faster and cheaper. This is the content of the Riksbank's annual Payments Report, which is

Terveystalo Plc: Managers’ Transactions (Michelet)

Terveystalo Plc: Managers’ Transactions (Michelet)   Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET   On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 1,421 shares have been purchased

Terveystalo Plc: Managers’ Transactions (Kauniskangas)

Terveystalo Plc: Managers’ Transactions (Kauniskangas) Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 3,002 shares have been purchased to Kari

Terveystalo Plc: Managers’ Transactions (Mokkila)

Terveystalo Plc: Managers’ Transactions (Mokkila) Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 1,421 shares have been purchased to Niko

Terveystalo Plc: Managers’ Transactions (Viippola)

Terveystalo Plc: Managers’ Transactions (Viippola) Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 1,421 shares have been purchased to Katri

Terveystalo Plc: Managers’ Transactions (Von Rettig)

Terveystalo Plc: Managers’ Transactions (Von Rettig) Terveystalo Plc, Managers’ transactions, 3 November, 2021 at 10:30 EET On 25 March 2021, Terveystalo Plc’s Annual General Meeting resolved that the annual remuneration of the Board will be paid as a combination of Company's shares and cash in such a manner that 40% of the annual remuneration is paid in shares in the possession of the Company or, if this is not possible, in the Company's shares purchased from the market, and 60% is paid in cash. In accordance with this resolution, a total of 1,783 shares have been purchased to Tomas

polight ASA: SHARE CAPITAL INCREASE REGISTERED

Reference is made to previous announcements by poLight ASA (the "Company") regarding a subsequent offering of 116,396 new shares in the Company (the "Subsequent Offering" and the "Offer Shares"), each with a par value of NOK 0.20, and each Offer Share at a subscription price of NOK 110. Reference is furthermore made to the resolution by the general meeting of the Company on 26 May 2021 regarding an authorization to the board of directors of the Company to resolve certain share capital increases as registered in the Register of Business Enterprises on 19 July 2021 and  the subsequent

Reliability, flexibility and sustainability of Wärtsilä technology lands repeat order from Nigerian cement producer

Wärtsilä Corporation, Press release, 3 November 2021 at 10:15 AM EETThe technology group Wärtsilä will supply a 70 MW captive power plant for the BUA’s new Sokoto cement production plant in Nigeria. The new plant is required to supply the energy for an off grid additional cement production line. This follows an order for a 50 MW power plant from the same customer just two years earlier. This latest extended engineering and equipment order was booked in Wärtsilä’s order intake in October 2021. Both the current and 2019 orders feature Wärtsilä 34DF dual-fuel engines operating primarily

The Reissumies brand is campaigning for tolerance and men’s diversity

According to a survey ordered by Fazer, nearly half of Finnish men see male representation as narrow. The iconic Reissumies, beloved by many Finns, wants to broaden its male representation so that more men could feel accepted just as they are. Reissumies will feature new faces in its packaging in this autumn’s campaign.In November, Reissumies will feature new faces showing a new, more diverse male representation on a million bread bags.  This autumn’s Reissumies faces are diversity and inclusion consultant Dakota Robin, rap artist and children’s football coach PastoriPike and ice hockey

MOBILE PHONE ECO RATING SCHEME NOW INVITING MORE OPERATORS TO JOIN

· Consumer mobile phone labelling scheme launched in 24 European countries by Deutsche Telekom, Orange, Telefónica, Telia Company and Vodafone now set to expand globally · Fairphone, Realme and Vivo join Eco Rating, now 15 manufacturers in total · More than 150 mobile phone models now assessed by Eco Rating methodology 3 November 2021 – The new mobile phone Eco Rating scheme launched across Europe is set to roll out globally after the five operators behind the initiative expanded their initial agreement to encourage operators worldwide to participate. The

Titti Lilja new Business Area Manager of Individual & Family

Titti Lilja, today division manager within the Individual & Family business area, has been appointed Business Area Manager of the business area and a member of Humana's Group Management. She will take office in November.– I am very happy that Titti Lilja will be the new Business Area Manager of Individual & Family. Titti, who is a nurse, has many years of experience as a leader at various levels in health and care. She is a skilled leader and a team player, who will be able to take the business area to the next level both in terms of quality work as well as growth and development, Johanna

ABC Labs and Capitainer offer Covid-19 antibody testing using dried blood from self-sampling throughout Sweden

Trials show over 95% of Capitainer qDBS cards returned meet lab testing quality requirements Stockholm, Sweden, November 3, 2021. From November 8th, ABC-Labs will offer analysis of Covid-19 antibody levels on dried blood from self-sampling using the qDBS card developed by Capitainer, this year’s Guldpillret winner. The sampling method has been proven to both work well in home environments and be scalable during the pandemic. A qDBScard with clear simple to follow instructions is sent to the patient by regular post, the sample is then taken by the patient himself and the card is

ABC Labs and Capitainer offer Covid-19 antibody testing using dried blood from self-sampling throughout Sweden

Trials show over 95% of Capitainer qDBS cards returned meet lab testing quality requirements Stockholm, Sweden, November 3, 2021.From November 8th, ABC-Labs will offer analysis of Covid-19 antibody levels on dried blood from self-sampling using the qDBS card developed by Capitainer, this year’s Guldpillret winner. The sampling method has been proven to both work well in home environments and be scalable during the pandemic. A qDBScard with clear simple to follow instructions is sent to the patient by regular post, the sample is then taken by the patient himself and the card is

Aptahem has started the production of GMP certified Apta-1 for clinical trials

Aptahem can today announce that the production of Good Manufacturing Practice (GMP) manufacturing of the drug candidate Apta-1 has started at the collaboration partner LGC Biotechnologies’ facilities in the USA, with planned delivery date in early 2022. The GMP manufactured Apta-1 will be used in a product which can be administered to humans in a clinical trial.Further process development for the GMP manufacturing has been successful with both improved quality and exchange. Aptahem’s partner LGC has yet again improved the CoGs (Cost of Goods) which is an important part in creating an

BioStock: Immunicum’s vision for the cancer therapy landscape

Two of the biggest challenges in oncology are hard-to-treat solid tumours and tumour recurrence. Swedish biotech Immunicum are on a mission to tackle both challenges through their two cell-based immunotherapy candidates, ilixadencel and DCP-001. BioStock takes a closer look at the cancer therapy landscape and how Immunicum plans to make an impact.Read the article at biostock.se : https://www.biostock.se/en/2021/11/immunicums-vision-for-the-cancer-therapy-landscape/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Transcom Holding AB (publ): Invitation to Transcom third quarter 2021 results presentation webcast

Transcom are pleased to invite you to their Q3 2021 financial update webcast (live) on Wednesday, November 17, at 9:00 am CET, following the release of Q3 2021 results at 8:00 am CET. The Q3 report and presentation will be available on https://www.transcom.com/en/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Snejana Koleva, CFO Presentation details Date/Time: Wednesday, November 17, 2021 at 9:00 CET Online Registration link: https://app.livestorm.co/transcom-holding/transcom-holding-ab-q3-2021-results-presentation Important note: Please

BioStock: BioInvent offers guidance on upcoming milestones

When pharmaceutical company BioInvent recently invited investors, analysts and media to Stockholm, CEO Martin Welschof painted a picture of busy times ahead. BioStock had the privilege to chat with Welschof, who offered guidance on what to expect from the company in the upcoming months.Read the full interview with Martin Welschof at biostock.se: https://www.biostock.se/en/2021/11/bioinvent-offers-guidance-on-upcoming-milestones/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Issue and repurchase of class C shares for incentive program

The board of directors for Medicover AB (publ) has today resolved to issue 1,200,000 new class C shares and to immediately thereafter repurchase such 1,200,000 issued class C shares, for the purpose of the long term performance-based share programs for key individuals as approved by the annual general meetings held on 3 May 2019, 30 April 2020 and 29 April 2021 (the “Plan 2019”, the “Plan 2020” and the “Plan 2021”). Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on 29 April 2021. Nordea Bank Abp will

Lactoferrin supplements could aid recovery of COVID19

The findings of a study, headed by Dr Hamid Merchant from the Department of Pharmacy at the University of Huddersfield, is one of the first meta-analyses carried out using multiple independent lactoferrin research studies.  The study has made evident that the administration of lactoferrin, of which has proven to be a key ingredient for our natural defence systems against invading viruses, shows promising efficacy in reducing the risk of RTIs and also has the potential to be used adjunct to COVID19.THE antiviral properties of lactoferrin makes it a great natural supplement that could also be

Epiroc completes acquisition of specialist in mining vehicle battery conversions

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has completed the acquisition of the business and assets of FVT Research Inc., a Canadian company with expertise in converting diesel-powered mining machines to battery-electric vehicles.FVT Research, based in Vancouver, Canada, designs diesel-to-battery conversion kits and rebuilds mining machines to electric versions. The company has also recently been part of a successful project to convert the diesel-powered Epiroc Scooptram ST1030 loader to battery electric. FVT

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 2nd November 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,166,036 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

There are no items matching the current filter
There are no more items matching the current filter
Back to top